首页> 美国卫生研究院文献>other >Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles
【2h】

Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles

机译:天然高密度脂蛋白的性质激发了主动靶向体内siRNA传递载体的合成。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Efficient systemic administration of therapeutic short interfering RNA (siRNA) is challenging. High-density lipoproteins (HDL) are natural in vivo RNA delivery vehicles. Specifically, native HDLs: 1) Load single-stranded RNA; 2) Are anionic, which requires charge reconciliation between the RNA and HDL, and 3) Actively target scavenger receptor type B-1 (SR-B1) to deliver RNA. Emphasizing these particular parameters, we employed templated lipoprotein particles (TLP), mimics of spherical HDLs, and self-assembled them with single-stranded complements of, presumably, any highly unmodified siRNA duplex pair after formulation with a cationic lipid. Resulting siRNA templated lipoprotein particles (siRNA-TLP) are anionic and tunable with regard to RNA assembly and function. Data demonstrate that the siRNA-TLPs actively target SR-B1 to potently reduce androgen receptor (AR) and enhancer of zeste homolog 2 (EZH2) proteins in multiple cancer cell lines. Systemic administration of siRNA-TLPs demonstrated no off-target toxicity and significantly reduced the growth of prostate cancer xenografts. Thus, native HDLs inspired the synthesis of a hybrid siRNA delivery vehicle that can modularly load single-stranded RNA complements after charge reconciliation with a cationic lipid, and that function due to active targeting of SR-B1.
机译:治疗性短干扰RNA(siRNA)的有效全身给药具有挑战性。高密度脂蛋白(HDL)是天然的体内RNA传递载体。具体来说,天然HDL:1)加载单链RNA; 2)是阴离子性的,需要在RNA和HDL之间进行电荷调节,并且3)主动靶向B-1型清道夫受体(SR-B1)以递送RNA。强调这些特定的参数,我们采用模板化的脂蛋白颗粒(TLP),模拟球形HDL,并在与阳离子脂质配制后,将其与大概任何高度未修饰的siRNA双链体对的单链互补序列自组装。所得的siRNA模板化脂蛋白颗粒(siRNA-TLP)在RNA组装和功能方面是阴离子性的且可调节的。数据表明,siRNA-TLP主动靶向SR-B1,以有效降低多种癌细胞系中zeste同源2(EZH2)蛋白的雄激素受体(AR)和增强子。 siRNA-TLP的全身给药显示无脱靶毒性,并且显着降低了前列腺癌异种移植物的生长。因此,天然的HDL激发了杂化siRNA传递载体的合成,该载体可以在与阳离子脂质进行电荷调节后以模块化方式加载单链RNA补体,并且由于SR-B1的主动靶向而起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号